HIGH

Rising Pharmaceuticals Temozolomide 5 mg Capsules Recall 1,200 Bottles in 2026

Rising Pharmaceuticals recalls 1,200 Temozolomide 5 mg capsules nationwide after a stability test found out-of-spec impurities. The drug is Rx-only, with NDC 16571-816-51 and lot 1TM0524003A. Stop using immediately and contact a healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
March 3, 2026
Hazard Level
HIGH
Brands
Rising Pharmaceuticals, Temozolomide
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Rising Pharma Holding, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Temozolomide is a chemotherapy drug used in brain cancer treatment. The recall concerns impurities and degradation detected in stability testing.

Why This Is Dangerous

Out-of-spec impurities can cause unknown toxicity or reduced drug efficacy. A stability failure indicates potential safety risk.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients relying on Temozolomide may experience disruption in treatment. The recall affects 1,200 bottles nationwide and requires medical guidance.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 16571-816-51
  2. Check lot 1TM0524003A on the bottle
  3. Confirm Exp 09/2026 and 5 mg dosage

Where to find product info

NDC, lot number, and expiration appear on the bottle label. The recall URL provides official details.

What timeline to expect

Refunds or replacements, if offered, typically take 4-8 weeks after submission.

If the manufacturer is unresponsive

  • Document all communications with the manufacturer.
  • If the company is slow, contact the FDA recall page for guidance and report delays.
  • Consult your clinician for alternative treatments and prescriptions if needed.

How to prevent similar issues

  • Always verify NDC and lot numbers before dispensing Rx drugs.
  • Obtain Rx drugs from licensed pharmacies only.
  • Keep recall notices with medical records for future reference.

Documentation advice

Keep packaging, recall notification, and all correspondence for records.

Product Details

NDC: 16571-816-51. Lot: 1TM0524003A. Expiration: 09/2026. Quantity: 1,200 bottles. Distribution: Nationwide in the U.S. Manufactured for: Rising Pharmaceuticals, Allendale, NJ 07401. Country of origin: Taiwan.

Key Facts

  • 1,200 bottles recalled nationwide
  • NDC 16571-816-51; Lot 1TM0524003A; Exp 09/2026
  • Reason: out-of-spec impurities/degradation in stability testing
  • Remedy: stop use and contact physician or manufacturer
  • Recall status: ACTIVE; Hazard level HIGH

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot #: 1TM0524003A
UPC Codes
16571-816
16571-817
16571-818
+13 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more